Sustainability 2010 Goals

After conferring with hundreds of internal and external stakeholders, Bristol-Myers Squibb adopted comprehensive sustainability goals for 2010. We track our performance against these goals worldwide and report to the public on our progress, whether negative or positive. We strive to make our company more sustainable by meeting, and where relevant, exceeding these goals.

2010 Goals - Progress Report

The table below presents the company's status in meeting the Sustainability 2010 Goals. These goals were developed in 2000 as stretch goals for our company, and we anticipate achieving all of these goals by the end of 2010, although the pace of progress will differ by goal. Use the links in this report card, or scroll to the end of this page, to find more detailed information about each goal.

Category	2010 Goal	Status
Environmental, health, and safety (EHS) effects analysis	EHS effects analysis conducted by all manufacturing, research and development, and distribution facilities to identify their most significant EHS impacts and opportunities for improvement.	***
Safety performance targets to drive down reportable incidents and days lost from work.	Fifty-percent reduction in recordable and lost workday case rates based on 2000 base year. Maintain performance in top 25 percent of similar companies.	*
Environmental performance targets and goals (normalized by sales) to reduce water use, greenhouse gas emissions, energy use, wastewater, air emissions, hazardous waste, nonhazardous waste, and off-site releases of chemicals of high concern.	Reduce energy use by 10 percent from 2001 baseline year. Reduce water use by 10 percent from 2001 baseline year. In countries where water resources are severely stressed, reduce water use by 20 percent from 2002 baseline year. Reduce total greenhouse gas emissions (e.g., carbon dioxide and methane) by 10 percent from 2001 baseline year. Reduce nonhazardous waste by 20 percent from 2002 baseline year. Reduce off-site hazardous waste disposal by 50 percent from 2001 baseline year. Reduce air emissions of acid gases (sulfur oxides, nitrogen oxides, and hydrogen chloride) by 10 percent from 2003 baseline year. Reduce off-site release to air of priority reduction chemicals by 50 percent from 2002 baseline year. Reduce wastewater releases of total chemical oxygen demand, suspended solids, and nitrates by 10 percent from 2002 baseline.	**
Sustainable products promotion through packaging reductions, green chemistry, and inherent product and process safety.	Promote development of sustainable products, processes, and packaging to limit negative EHS impacts. Develop companywide metrics to track progress on key product, process, and packaging initiatives.	*
Supply chain partnership to promote EHS performance improvements among key suppliers.	Develop specific programs and expectations to improve EHS performance for key suppliers.	**
EHS research addressing business issues.	Research sponsored by the company for early study of emerging areas of concern, such as pharmaceuticals in the environment.	**
Sustainability awards initiated.	Awards to promote sustainability behavior among employees across the company.	*
Leadership development program established.	Program established to enhance EHS integration throughout the company.	**
Biotechnology development.	Support biotechnology development through sharing expertise on labeling, biosafety, and bioethics issues.	**
Community outreach	Provide support within each facility to enhance communications with neighbors on EHS and sustainability topics.	*
Social policies and metrics	Support development of policies and metrics to raise corporate awareness of emerging social issues.	*
EHS research contributions	Support funding through the Bristol-Myers Squibb Foundation and other sources to demonstrate the company's commitment to expand society's knowledge and understanding.	**
Endangered species sponsorship to encourage each facility and business to help protect local endangered species and habitats.	In countries and U.S. states where our manufacturing, research and development, and distribution sites are located, Bristol-Myers Squibb will sponsor a local endangered or threatened species or will partner with an organization that protects endangered local species and their habitats.	***
Land preservation of biologically diverse land to offset the property used by Bristol-Myers Squibb's total operations worldwide and to promote employee participation in protecting critical land areas.	Conserve ecologically significant areas to offset the property occupied by Bristol-Myers Squibb total operations worldwide, including manufacturing, research and development, distribution, and administrative offices. Encourage local site conservation projects. Promote employee participation in the protection of critical land areas.	***

*** = On track to exceed 2010 goal
** = On track to meet 2010 goal
* = Needs improvement to be on track to meet 2010 goal

2010 Goals: Details by Category

Facility EHS Effects Analysis

This goal has been met for both environmental and health and safety assessments.

Safety Performance

From 2000 to 2007, the company achieved a 35% reduction in the recordable case rate and has maintained the days away from work case rate.

Key Performance Indicator	Baseline Year	Baseline Performance	2007 Performance	Baseline Year - 2007 Performance (% Change)	2010 Goal (%)	2010 Goal (Value)
Health and Safety
Recordable case rate (cases/100 employees)	2000	1.3	0.85	-35%	-50%	0.7
Lost workday case rate (cases/100 employees)	2000	0.34	0.34	0%	-50%	0.17

Environmental Performance

Our performance for each of the environmental performance targets (normalized by sales) from 2007 to the baseline year is as follows.

Key Performance Indicator	Baseline Year	Baseline Performance	2007 Performance	Baseline Year - 2007 Performance (% Change)	2010 Goal (%)	2010 Goal (Value)
Energy use
Total energy use, direct and indirect (megaJoules/$1,000 sales)	2001	1,233	1,010	-18%	-10%	1,110
Air emissions
Total greenhouse gas emissions (kg/$1,000 sales)	2001	67	53	-21%	-10%	60
Air emission of priority reduction chemicals (kg/$1,000 sales)	2002	0.14	0.07	-50%	-50%	0.07
Acid gas emissions (NOx, SOx, HCl) (g/$1,000 sales)	2003	31	16	-49%	-10%	28
Waste
Hazardous waste off-site treatment/ disposal (kg/$1,000 sales)	2001	0.48	0.2	-59%	-50%	0.24
Nonhazardous waste disposed (kg/$1,000 sales)	2002	2.36	1.38	-41%	-20%	1.89
Water Use
Water use (liters/$1,000 sales)	2001	2,217	1,766	-20%	-10%	1,995
Water use from stressed areas* (percent of countries achieving goal)	2002	0	44	NA	100%	9 countries
Effluents to Water
Discharge of general pollutants (g/$1,000 sales)	2002	211	117	-45%	-10%	190
Biodiversity
Endangered and Threatened Species Adoption	2000	0	15 countries and U.S. states	NA	100%	30 countries and U.S. states
Land Preservation
Biologically diverse land preservation (hectares)	2000	1,336	1,616	NA	100%	1,589

* The 2010 goal for water use from stressed areas has been reduced due to a plant closure.

Bristol-Myers Squibb will review the environmental performance indicators periodically to ensure that they are appropriate and challenging goals for a leadership company.

Sustainable Products

Bristol-Myers Squibb is reviewing the goals for sustainable packaging. A representative from the packaging function is a member of the companywide EHS Steering Committee and serves as liaison between the packaging organization and the EHS function. The company conducted a benchmarking survey of packaging goals among other companies across industry sectors.

Supply Chain Partnership

The company signed a letter of participation in a Green Suppliers Network with five other pharmaceutical companies and the U.S. Environmental Protection Agency. The company has been active in supporting supplier programs in Puerto Rico and Mexico.

EHS Research

Bristol-Myers Squibb is establishing a mechanism for ongoing identification and prioritization of projects and identifying potential funding sources.

Sustainability Award

Plans are in place to develop a framework for this award program.

Leadership Development

The company has incorporated EHS and sustainability examples into the company's Core Behaviors training and has developed an EHS/Sustainability orientation brochure for new executives.

Biotechnology Development

An internal Bioethics Committee has been formed and has issued global policies and implemented training.

Community Outreach

Bristol-Myers Squibb provides facility environmental, social, and economic information on the corporate sustainability website.

Social Policies and Metrics

A cross-functional team has been established and will propose social metrics to measure performance in implementing the Bristol-Myers Squibb Pledge.

Research Contributions

Bristol-Myers Squibb is a supporting member of the Environmental Associates, a group of leading industries that work in cooperation with the Academy of Natural Sciences in Philadelphia, Pennsylvania, to conduct research and inform the public about environmental topics. As part of this effort to inform the public, the associates and the Academy of Natural Sciences produce the Know Your Environment series. These articles are sent free of charge to thousands of newspapers, magazines, environmental organizations, reporters, legislators, educators, and individuals – and they are now available to anyone with access to the World Wide Web. They provide a more in-depth explanation of the science behind the issues that are often reported in the popular media. Our association with the Academy of Natural Sciences and our financial support for the Environmental Associates represents one example of how we are working to meet our 2010 Sustainability Goal on Environmental Stewardship, which calls for sponsoring EHS research through various funding sources to demonstrate our commitment to expand society's knowledge and understanding.

Bristol-Myers Squibb also funded a $100,000 project in Puerto Rico to create a biodiversity planning map, in conjunction with The Nature Conservancy, an internationally respected environmental conservation organization.

Endangered Species

The following sites have adopted endangered or protected species:

Facility Location	Endangered Species
Agen, France	European Pond Turtle
Bangkok, Thailand	Elephant
Cibinong Bogor, Indonesia	Komodo Dragon
Cruiserath, Ireland	Marsh Fritillary Butterfly
Devens, Massachusetts, U.S.	Blanding Turtle
Evansville, Indiana, U.S.	Peregrine Falcon
Hopewell, New Jersey, U.S.	Marsh Hawk (Northern Harrier / Circus cyaneus)
Humacao, Puerto Rico, U.S.	Humacao Wildlife Reserve (various)
Lawrenceville, New Jersey, U.S.	Cooper's Hawk (Accipiter cooperii)
Mayagüez, Puerto Rico, U.S.	Leather Back Sea Turtle and Cobana Negra
Moreton, UK	Natterjack Toad
New Brunswick, New Jersey, U.S.	Yellow Giant Hyssop (Agastache eptoides)
New York, New York, U.S.	Peregrine Falcon
Plainsboro, New Jersey, U.S.	Bobolink (dolichonyx oryzivorus)
San Angel, Mexico	Puma
São Paulo, Brazil	Brazil Nut Tree, Blue Macaw
Shanghai, China	Tiger
Swords, Ireland	River Otter
Syracuse, New York, U.S.	Chittenango Ovate Amber Snail
Tlalpan, Mexico	Puma
Victoria, Australia	Brush-tailed Rock Wallaby
Wallingford, Connecticut, U.S.	Stiff or Prairie Goldenrod (Solidago rigida)

Land Preservation

As of the end of 2007, Bristol-Myers Squibb has funded conservation of 1,616 hectares of biologically diverse habitat in Australia, Brazil, Indonesia, Ireland, Mexico, China, Canada and the United States.

In 2006, working through Wetlands International-China, Bristol-Myers Squibb adopted 16.5 acres of wetland at the Yalujiang National Nature Reserve. This is a rich wetlands and wildlife protection area for bird migration. The bird migration path stretches from Alaska in the United States to China, Asia, and down to Australia and New Zealand. This is the first time that a multinational company has adopted wetlands in China for environmental preservation.

Additional site conservation projects are underway. Several Bristol-Myers Squibb facilities support local programs -- and encourage employee participation in projects -- that protect critical land areas. These projects are often undertaken in conjunction with the endangered species 2010 goal.

Last updated August 3, 2008 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

Also in this section:

Vision and Strategy

Sustainability 2010 Goals:

Background

Details by category

Critical success factors

EHS Policy translated for our visitors who speak...